Pharma Excellence in the CEE, CIS, SEE & Turkey event 2012

CEE, CIS together with SEE and Turkey represent attractive arenas for pharma companies due to the wide availability of untreated patients, insufficient access to preventive medicine as well as lower costs. Recent tendencies of rising healthcare costs, increasing power of payers together with cost-containment measures implemented by governments generate the need to address this new market reality.
These and many other challenges that all industry stakeholders are facing in the region, will be discussed at the Pharma Excellence in the CEE, CIS, SEE & Turkey event.

Find Your Reasons To Attend

-2-day conference, 17 topics divided into 5 diverse sessions presented from various perspectives, each followed by the Interactive Questions & Answers session
-interactive and vigorous debates, dynamic panel discussions and presentations led by prominent speakers with extensive knowledge and experience in various aspects of the pharma industry from different countries throughout CEE & CIS
-the most pressing issues related to the market access, sales & marketing in the CEE & CIS from different perspectives – industry, regulatory, patient
-extensive networking opportunities during the coffee breaks, luncheons and evening receptions as well as possibility to share your ideas with the key industry stakeholders

Who Should Attend

CxOs Senior Vice Presidents, Vice Presidents, Senior Executives, Managing Directors, Country Heads, Country Managers and Heads of:
Pricing & Reimbursement • Health Outcomes • Health Economics & Pricing • Health Economy • Government Affairs • Regulatory Affairs •Public Affairs • Corporate Affairs • Business Development • Business Units • Sales & Marketing • Sales Force Effectiveness • Sales Operations • Key Account Management • Commercial Excellence
CEE – Hungary, Poland, Czech Republic, Slovakia, Austria
CIS – Lithuania, Latvia,